Chemical Compound

(R)-2-((2R,3S,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)butanoic acid

CAS Registry Number 55134-13-9
返回搜索 申请报价
(R)-2-((2R,3S,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)butanoic acid 结构式
Primary record

(R)-2-((2R,3S,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)butanoic acid

库存
4,418 克
纯度
99.7 %
CAS
55134-13-9

化合物标识与属性

CAS
55134-13-9
PubChem CID
65452
SMILES
CC[C@H]([C@H]1[C@H](C[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C)C(=O)O
Canonical SMILES
CC[C@@H](C(=O)O)[C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@]3(C=C[C@@H](O)[C@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C

名称与同义词

  • narasin
  • Narasin A
  • Monteban
  • Narasine
  • Narasinum
  • narasina
  • Narasino
  • Compound 79891
  • 4-Methylsalinomycin
  • Narasul
  • Skycis
  • Antibiotic C 7819B
  • Narasia A
  • Lilly 79891
  • Antibiotic A 28086A
  • Monteban 45
  • Monteban (TN)
  • Narasine [INN-French]
  • Narasinum [INN-Latin]
  • Maxiban 72
  • 55134-13-9
  • Narasino [INN-Spanish]
  • Antibiotic A-28086 factor A
  • (4S)-4-Methylsalinomycin
  • Skycis 100
  • Compound-79891
  • Narasin (USP/INN)
  • DZY9VU539P
  • RefChem:58603
  • UNII-DZY9VU539P
  • NARASIN [USAN]
  • NARASIN [INN]
  • Salinomycin, 4-methyl-, (4S)-
  • NARASIN [MI]
  • NARASIN [MART.]
  • Narasin [USAN:BAN:INN]
  • NARASIN [USP-RS]
  • DTXSID2046707
  • COMPD-79891
  • C-7819B
  • Narasin [USAN:INN:BAN]
  • DTXCID0026707
  • NARASIN [GREEN BOOK]
  • Narasin [USAN:USP:INN:BAN]
  • Salinomycin, 4-methyl-, (4S)
  • SCHEMBL123401
  • (4S)-4beta-Methylsalinomycin
  • C 7819B
  • C43H72O11
  • NARASIN [USP IMPURITY]
  • AC1L23A4
  • orb1705989
  • A 28086A
  • CHEMBL2104423
  • GTPL10835
  • BRN 1678311
  • MSK7605
  • CHEBI:183815
  • VHKXXVVRRDYCIK-CWCPJSEDSA-N
  • (4''S'')-4-methyl-salinomycin
  • GLXC-25036
  • CID65452
  • AI3-29798
  • Tox21_112545
  • BBF-02573
  • ZINC85540282
  • Narasin from Streptomyces auriofaciens
  • AKOS040744425
  • MSK7605-1000M
  • AN26161
  • DB11432
  • Narasin 100 microg/mL in Acetonitrile
  • C43-H72-O11
  • Narasin 1000 microg/mL in Acetonitrile
  • NCGC00167550-01
  • NCGC00167550-06
  • NCGC00167550-08
  • A-28086A
  • J12.902J
  • Narasin Solution in Methanol, 1000ug/mL
  • CAS-55134-13-9
  • HY-121410
  • LS-144430
  • CS-0081972
  • NS00000173
  • D05122
  • F82330
  • A1032337
  • Q2104314
  • (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
  • 6-CHLORO-5-CYANO-4-METHOXY-2-METHYL-3-NITROPYRIDINE
  • alpha-Ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2H-pyran-2-acetic acid
  • 2H-Pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-
  • (2R)-2-((2R,3S,5S,6R)-6-((2S,3S,4S,6R)-6-((3S,5S,7R,9S,10S,12R,15R)-3-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl)-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro(4.1.57.35)pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-3,5-dimethyloxan-2-yl)butanoic acid
  • (2R)-2-[(2R,3S,5S,6R)-6-[(1S,2S,3S,5R)-5-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyl-tetrahydropyran-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxo-heptyl]-3,5-dimethyl-tetrahydropyran-2-yl]butanoic acid
  • (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
  • (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
  • (2R)-2-{(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-Ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5~7~.3~5~]pentadec-13-en-9-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl}butanoic acid
  • (R)-2-((2R,3S,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)butanoic acid
  • 2-(6-(5-(2-(5-Ethyltetrahydro-5-hydroxy-6-methylpyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethylpyran-2-yl)butyric acid